Literature DB >> 3275103

Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine.

S Nagamachi1, H Hoshi, S Jinnouchi, S Ono, K Watanabe.   

Abstract

Gallium scintigraphy was performed as an aid for determining the presence or absence of malignant neoplasm in two patients with hemochromatosis treated by deferoxamine. However, gallium scan images could not be obtained. So gallium scintigraphy was performed once more to investigate the cause of low activity. Both patients had heavy urinary excretion of gallium in the first 24 hrs after the injection, and activity was very low on the day of examination. This phenomenon may be attributed to the effect of deferoxamine which is highly bound to the gallium.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3275103     DOI： 10.1007/bf03164584

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN： 0914-7187            Impact factor:   2.668


  14 in total

1.  The behaviour of tracer gallium-67 towards serum proteins.

Authors:  S W Gunasekera; L J King; P J Lavender
Journal:  Clin Chim Acta       Date:  1972-07       Impact factor: 3.786

2.  The binding of gallium by blood serum.

Authors:  R E Hartman; R L Hayes
Journal:  J Pharmacol Exp Ther       Date:  1969-07       Impact factor: 4.030

3.  Radiogallium localization in tumors: blood binding and transport and the role of transferrin.

Authors:  S R Vallabhajosula; J F Harwig; J K Siemsen; W Wolf
Journal:  J Nucl Med       Date:  1980-07       Impact factor: 10.057

4.  Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.

Authors:  K Koizumi; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1982

5.  Continuous intravenous deferoxamine infusion. Treatment of secondary hemochromatosis in adults.

Authors:  K G Blume; E Beutler; R K Chillar; J L Fahey; D Sharkoff; P K Zia
Journal:  JAMA       Date:  1978-05-19       Impact factor: 56.272

6.  The effects of deferoxamine mesylate on gallium-67 distribution in normal and abscess-bearing animals: concise communication.

Authors:  Z H Oster; P Som; D F Sacker; H L Atkins
Journal:  J Nucl Med       Date:  1980-05       Impact factor: 10.057

7.  Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 sarcoma (BALB/c mice).

Authors:  S M Larson; J S Rasey; Z Grunbaum; D R Allen
Journal:  Radiology       Date:  1979-01       Impact factor: 11.105

8.  Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions.

Authors:  M J Pippard; S T Callender; G T Warner; D J Weatherall
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

9.  Effect of iron deficiency on the biodistribution and tumor uptake of Ga-67 citrate in animals: concise communication.

Authors:  W P Bradley; P O Alderson; J F Weiss
Journal:  J Nucl Med       Date:  1979-03       Impact factor: 10.057

10.  Effect of desferoxamine on tissue and tumor retention of gallium-67: concise communication.

Authors:  P B Hoffer; A Samuel; J T Bushberg; M Thakur
Journal:  J Nucl Med       Date:  1979-03       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.